Myelodysplasia and the Acute Myeloid Leukaemias

References

• Rossi, G., Pelizzari, A.M., Bellotti, D., Tonelli, M. and Barlati, S. (2000) "Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients", Leukemia 14, 636–641.
   PubMed Web of Science ®Google Scholar
• Lichtman, M.A. (2000) "Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases", Blood Cells Mol. Dis. 26, 572–581.
   PubMed Web of Science ®Google Scholar
• Heaney, M.L. and Golde, D.W. (1999) "Myelodysplasia", N. Engl. J. Med. 340, 1649–1660, Table reproduced with acknowledgement and permission from the Massachusetts Medical Society: Copyright © 1999. All rights reserved.
   PubMed Web of Science ®Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1982) "Proposals for the classification of the myelodysplastic syndromes. The French—American—British (FAB) Co-operative Group", Br. J. Haematol. 51, 189–199.
   PubMed Web of Science ®Google Scholar
• Miyazato, A., Ueno, S., Ohmine, K., Ueda, M., Yoshida, K., Yamashita, Y, et al. (2001) "Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction", Blood 98, 422–427.
   PubMed Web of Science ®Google Scholar
• van de Loosdrecht, A.A. and Vellenga, E. (2000) "Myelodys-plasia and apoptosis: new insights into ineffective erythro-poiesis", Med. Oncol. 17, 16–21.
   PubMed Web of Science ®Google Scholar
• Seo, IS., Li, C.Y. and Yam, L.T. (1993) "Myelodysplastic syndrome: diagnostic implications of cytochemical and immunocytochemical studies", Mayo Clin. Proc. 68, 47–53.
   PubMed Web of Science ®Google Scholar
• Greenberg, P.L. (1996) "Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes", Semin. Hematol. 33, 163–175.
   PubMed Web of Science ®Google Scholar
• Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood 89, 2079-2088, Erratum publ. in: Blood (1998) 33, 1100.
   PubMed Web of Science ®Google Scholar
• Balduini, C.L., Guarnone, R., Pecci, A., Centenara, E., Invernizzi, R. and Ascari, E. (1999) "The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution", Haematologica 84, 12–16, Table IV from this issue of Haematologica reproduced with acknowledgement and permission: Copyright © 1999. All rights reserved.
   PubMed Web of Science ®Google Scholar
• Mijovié, A. and Mufti, G.J. (1998) "The myelodysplastic syndromes: towards a functional classification", Blood Rev. 12, 73–83.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., et al. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997", J. Clin. Oncol. 17, 3835–3849.
   PubMed Web of Science ®Google Scholar
• Sperr, W.R., Wimazal, F., Kundi, M., Fonatsch, C., Thalhammer-Scherrer, R., Schernthaner, G.H., et al. (2001) "Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems", Ann. Hematol. 80, 272–277, Table DI from this issue of Annals Hematology reproduced with acknowledgement and permission: Copy-right © 2001. All rights reserved.
   PubMed Web of Science ®Google Scholar
• Germing, U., Gattermann, N., Minning, H., Heyll, A. and Aul, C. (1998) "Problems in the classification of CMML—dysplastic versus proliferative type", Leuk. Res. 22, 871–878.
   PubMed Web of Science ®Google Scholar
• Dickstein, J.I. and Vardiman, J.W. (1993) "Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes", Am. J. Clin. Pathol. 99, 513–525.
   PubMed Web of Science ®Google Scholar
• Greenberg, P., Anderson, J., De Witte, T., Estey, E., Fenaux, P., Gupta, P., et al. (2000) "Problematic WHO reclassification of myelodysplastic syndromes. The Members of the Inter-national MDS Study Group", J. Clin. Oncol. 18, 3447–3449.
   PubMed Web of Science ®Google Scholar
• Estey, E.H., Pierce, S. and Keating, M.J. (2000) "Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities", Haematologica 85, 246–249.
   PubMed Web of Science ®Google Scholar
• Luna-Fineman, S., Shannon, K.M., Atwater, S.K., Davis, J., Masterson, M., Ortega, J., et al. (1999) "Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients", Blood 93, 459–466.
   PubMed Web of Science ®Google Scholar
• Antunovic, P., Marisavljevic, D., Novak, A. and Mijovic, A. (1998) "Familial myelodysplastic syndrome/acute myeloid leukaemia with monosomy 7: report of a new kindred", Hematology 3, 31–36.
   PubMedGoogle Scholar
• Cheson, B.D., Zwiebel, J.A., Dancey, J. and Murgo, A. (2000) "Novel therapeutic agents for the treatment of myelodys-plastic syndromes", Semin. Oncol. 27, 560–577.
   PubMed Web of Science ®Google Scholar
• Raza, A., Qawi, H., Lisak, L., Andric, T., Dar, S., Andrews, C., et al. (2000) "Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone", Blood 95, 1580–1587.
   PubMed Web of Science ®Google Scholar
• De Witte, T., Van Biezen, A., Hermans, J., Labopin, M., Runde, V, Or, R., et al. (1997) "Autologous bone marrow transplan-tation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. The Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation", Blood 90, 3853–3857.
   PubMed Web of Science ®Google Scholar
• Wäsch, R., Bertz, H., Kunzmann, R. and Finke, J. (2000) "Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation", Br. J. Haematol. 109, 743–750.
   PubMed Web of Science ®Google Scholar
• Jacobs, P., Wood, L., Fullard, L., Waldmann, H. and Hale, G. (1994) "T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease", Bone Marrow Transplant. 13, 763–769.
   PubMed Web of Science ®Google Scholar
• Jackson, G., Taylor, P., Smith, G.M., Marcus, R., Smith, A., Chu, P., et al. (2001) "A multicentre, open, non-comparative phase 11 study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation", Br. J. Haematol. 112, 127–137.
   PubMed Web of Science ®Google Scholar
• Diamandis, E.P. (2000) "Sequencing with microarray tech-nology—a powerful new tool for molecular diagnosis", Clin. Chem. 46, 1523–1525.
   PubMed Web of Science ®Google Scholar
• Piller, G.J. (2001) "Leukaemia—a brief historical review from ancient times to 1950", Br. J. Haematol. 112, 282–292.
   PubMed Web of Science ®Google Scholar
• Hayhoe, F.G.J. (1988) "Classification of acute leukaemias", Blood Rev. 2, 186–193.
   PubMed Web of Science ®Google Scholar
• Löwenberg, B., Downing, J.R. and Burnett, A. (1999) "Acute myeloid leukemia", N. Engl. J. Med. 341, 1051–1062, Table reproduced with acknowledgement and permission from the Massachusetts Medical Society: Copyright © 1999. All rights reserved.
   PubMed Web of Science ®Google Scholar
• Jacobs, P. (1997) "Myelodysplasia and the leukemias", Disease-a-Month 43, 505–600.
   PubMed Web of Science ®Google Scholar
• Southam, C.M., Craver, L.F., Dargeon, H.W. and Burchenal, J.H. (1951) "A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions", Cancer 4, 39–59.
   PubMed Web of Science ®Google Scholar
• Sayers, G.W., Rip, M.R., Jacobs, P, Klopper, J.M.L., Karabus, C.D., Rosenstrauch, W.J., et al. (1992) "Epidemiology of acute leukaemia in the Cape province of South Africa", Leuk. Res. 16, 961–966.
   PubMed Web of Science ®Google Scholar
• Russell, N.H. (1997) "Biology of acute leukaemia", Lancet 349, 118–122.
   PubMed Web of Science ®Google Scholar
• McKenna, R.W. (2000) "Multifaceted approach to the diagnosis and classification of acute leukemias", Clin. Chem. 46, 1252–1259, Table I from this issue of Clinical Chemistry reproduced with acknowledgement and permission.
   PubMed Web of Science ®Google Scholar
• Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. and van't Veer, M.B. (1995) "Proposals for the immunological classification of acute leukemias. The Euro-pean Group for the Immunological Characterization of Leukemias (EGIL)", Leukemia 9, 1783–1786.
   PubMed Web of Science ®Google Scholar
• Legrand, O., Perrot, J.Y., Baudard, M., Cordier, A., Lautier, R., Simonin, G., et al. (2000) "The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score", Blood 96, 870–877.
   PubMed Web of Science ®Google Scholar
• Bain, B.J. (1998) "Classification of acute leukaemia: the need to incorporate cytogenetic and molecular genetic infor-mation", J. Clin. Pathol. 51, 420–423.
   PubMed Web of Science ®Google Scholar
• Wheatley, K., Burnett, A.K., Goldstone, A.H., Gray, R.G., Hann, I.M., Harrison, C.J., et al. (1999) "A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial", Br. J. Haematol. 107, 69–79.
   PubMed Web of Science ®Google Scholar
• Crane, M.M., Strom, S.S., Halabi, S., Berman, E.L., Fueger, J.J., Spitz, M.R. and Keating, M.J. (1996) "Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia", Cancer Epidemiol. Biomark. Prey. 5, 639–644.
   PubMed Web of Science ®Google Scholar
• Creutzig, U., Zimmermann, M., Ritter, J., Henze, G., Graf, N., Löffler, H. and Schellong, G. (1999) "Definition of a standard-risk group in children with AML", Br. J. Haematol. 104, 630–639.
   PubMed Web of Science ®Google Scholar
• Rombouts, W.J., Löwenberg, B., van Putten, W.L. and Ploemacher, R.E. (2001) "Improved prognostic significance of cytokine-induced proliferation in vitro in patients with de novo acute myeloid leukemia of intermediate risk: impact of internal tandem duplications in the Flt3 gene", Leukemia 15, 1046–1053.
   PubMed Web of Science ®Google Scholar
• Schwartz, S., Heinecke, A., Zimmermann, M., Creutzig, U., Schoch, C., Harbott, J., et al. (1999) "Expression of the c-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogeneti-cally good-risk AML, and lacks prognostic significance", Leuk. Lymphoma 34, 85–94.
   PubMed Web of Science ®Google Scholar
• Filipits, M., Stranzl, T., Pohl, G., Heinzl, H., Jager, U., Geissler, K., et al. (2000) "Drug resistance factors in acute myeloid leukemia: a comparative analysis", Leukemia 14, 68–76.
   PubMed Web of Science ®Google Scholar
• Creutzig, U., Ritter, J., Zimmermann, M., Reinhardt, D., Hermann, J., Berthold, F., et al. (2001) "Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of study Acute Myeloid Leukemia-Berlin-Frankfurt-Miinster 93", J. Clin. Oncol. 19, 2705–2713.
   PubMed Web of Science ®Google Scholar
• Gluckman, E. (2001) "Hematopoietic stem-cell transplant-ation using umbilical-cord blood", N. Engl. J. Med. 344, 1860–1861.
   PubMed Web of Science ®Google Scholar
• Frassoni, F., Labopin, M., Powles, R., Mary, J.Y., Arcese, W., Bacigalupo, A., et al. (2000) "Effect of center on outcome of bone-marrow transplantation for acute myeloid leukaemia", Lancet 355, 1393–1398.
   PubMed Web of Science ®Google Scholar
• Tallman, MS., Rowlings, P.A., Milone, G., Zahng, M.J., Perez, W.S., Weisdorf, D., et al. (2000) "Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission", Blood 96, 1254–1258.
   PubMed Web of Science ®Google Scholar
• Cahn, J.Y., Labopin, M., Mandelli, E, Goldstone, A.H., Eberhardt, K., Reiffers, J., et al. (1995) "Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group", Blood 85, 575–579.
   PubMed Web of Science ®Google Scholar
• Singhal, S., Powles, R., Treleaven, J., Kulkarni, S., Horton, C. and Mehta, J. (1999) "Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation", Bone Marrow Transplant. 23, 875–879.
   PubMed Web of Science ®Google Scholar
• Appelbaum, F.R. (1999) "Antibody-targeted therapy for myeloid leukemia", Semin. Hematol. 36\(Suppl. 6), 2–8.
   PubMedGoogle Scholar